ORPHAZYME
Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases, and is based on discoveries emerging from the academic laboratory of its scientific founders: Professor Marja Jäättela and Thomas Kirkegaard Jensen from the Danish Cancer Society (Kræftens Bekæmpelse). Orphazyme is based in Copenhagen and has established collaborations with top-tier academic institutions in Europe and USA.
ORPHAZYME
Industry:
Biotechnology Genetics Health Diagnostics Therapeutics
Founded:
2009-01-01
Address:
Copenhagen, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.orphazyme.com
Total Employee:
51+
Status:
Active
Contact:
45 70 70 29 80
Email Addresses:
[email protected]
Total Funding:
263.34 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Bluebird Bio
Bluebird Bio offers products based on the transformative potential of gene therapy for patients with genetic and orphan diseases.
Denali Therapeutics
Denali Therapeutics is dedicated to defeating neurodegenerative diseases to deliver safe and effective medicines to patients and families.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Coave Therapeutics
Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.
Oxford BioMedica
Oxford BioMedica is a pioneer of gene and cell therapy, with a leading industry position in lentiviral vector and cell therapy research.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Kurma Partners
Kurma Partners investment in Post-IPO Equity - Orphazyme
Sunstone Life Science Ventures
Sunstone Life Science Ventures investment in Post-IPO Equity - Orphazyme
Life Sciences Partners
Life Sciences Partners investment in Post-IPO Equity - Orphazyme
Idinvest Partners
Idinvest Partners investment in Post-IPO Equity - Orphazyme
Novo Holdings
Novo Holdings investment in Post-IPO Equity - Orphazyme
Aescap Venture
Aescap Venture investment in Post-IPO Equity - Orphazyme
ALS Investment Fund
ALS Investment Fund investment in Venture Round - Orphazyme
Kurma Partners
Kurma Partners investment in Venture Round - Orphazyme
Aescap Venture
Aescap Venture investment in Venture Round - Orphazyme
Sunstone Life Science Ventures
Sunstone Life Science Ventures investment in Venture Round - Orphazyme
Official Site Inspections
http://www.orphazyme.com Semrush global rank: 4.16 M Semrush visits lastest month: 2.85 K
- Host name: 188.166.160.142
- IP address: 188.166.160.142
- Location: Frankfurt am Main Germany
- Latitude: 50.1188
- Longitude: 8.6843
- Timezone: Europe/Berlin
- Postal: 60313
